EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma

Ying Fu, Xujun Liang, Xinming Yang, Jianping Liu, Huichao Huang, Pengfei Zhang, Shisheng Li, Dandan Zhu, Ye Zhang, Fang Peng, Yongheng Chen, Zhuchu Chen

Molecular & Cellular Proteomics · 2023-06 · 22 (6) · 100567

DOI: 10.1016/j.mcpro.2023.100567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2023-06. Verfasst von Ying Fu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, NHC Key Laboratory of Cancer Proteomics & State Local Joint Engineering Laboratory for Anticancer Drugs, National Clinical Re…. Hauptthemen laut MEDLINE: Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nasopharyngeal carcinoma (NPC), a malignant tumor distinctly characterized by ethnic and geographic distribution, is highly prevalent in Southern China and Southeast Asia. However, the molecular mechanisms of NPC have not been fully revealed at the proteomic level. In this study, 30 primary NPC samples and 22 normal nasopharyngeal epithelial tissues were collected for proteomics analysis, and a relatively complete proteomics landscape of NPC was depicted for the first time. By combining differential expression analysis, differential co-expression analysis, and network analysis, potential biomarkers and therapeutic targets were identified. Some identified targets were verified by biological experiments. We found that 17-AAG, a specific inhibitor of the identified target heat shock protein 90 (HSP90), could be a potential therapeutic drug for NPC. Finally, consensus clustering identified two NPC subtypes with specific molecular features. The subtypes and the related molecules were verified by an independent data set and may have different progression-free survival. The results of this study provide a comprehensive understanding of the proteomics molecular signatures of NPC and provide new perspectives and inspiration for prognostic determination and treatment of NPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinomaNasopharyngeal NeoplasmsHumansNasopharyngeal CarcinomaProteomicsBiomarkers, Tumor

Stichwörter der Autor:innen

molecular signaturesnasopharyngeal carcinomanasopharyngeal carcinoma subtypeproteomicstherapeutic targets

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oncology, NHC Key Laboratory of Cancer Proteomics & State Local Joint Engineering Laboratory for Anticancer Drugs, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South…
  • Department of Otolaryngology Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Institute for Advanced Study, Central South University, Changsha, Hunan, China.

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Central South University
  • Hunan Provincial Science and Technology Department

Zitieren

APA

Fu, Y., Liang, X., Yang, X., Liu, J., Huang, H., Zhang, P., Li, S., Zhu, D., Zhang, Y., Peng, F., Chen, Y., & Chen, Z. (2023). Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma. Molecular & Cellular Proteomics, 22(6), 100567. https://doi.org/10.1016/j.mcpro.2023.100567

Vancouver

Fu Y, Liang X, Yang X, Liu J, Huang H, Zhang P, et al. Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma. Molecular & Cellular Proteomics. 2023;22(6):100567. doi:10.1016/j.mcpro.2023.100567

BibTeX
@article{Fu2023,
  author = {Fu, Ying and Liang, Xujun and Yang, Xinming and Liu, Jianping and Huang, Huichao and Zhang, Pengfei and Li, Shisheng and Zhu, Dandan and Zhang, Ye and Peng, Fang and Chen, Yongheng and Chen, Zhuchu},
  title = {Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma},
  journal = {Molecular & Cellular Proteomics},
  year = {2023},
  volume = {22},
  number = {6},
  pages = {100567},
  doi = {10.1016/j.mcpro.2023.100567}
}
Kostenlos starten →